Barclays’s PetMed Express PETS Stock Holding History

Barclays’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-200	Closed	-$7K	–	7060
2017 Q3	$7K	Buy	+200	New	+$8.14K	﹤0.01%	6294

Other funds holding PETS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

SPH

Steel Partners Holdings New York $96.4M AUM

Barclays's PETS Position: Q4 2025 in Review

Barclays sold out of PetMed Express (PETS) in Q4 2025, closing a stake of 57 shares — an estimated $143 sold.

Barclays first reported a position in PETS in Q2 2013 and held it in 43 quarters. The position peaked at $2.82M in Q2 2020. 51 funds tracked by Wall St. Rank hold PETS as of Q4 2025.

Barclays reported no remaining PetMed Express position as of Q4 2025 after selling out during the quarter.
Barclays sold 57 PetMed Express shares in Q4 2025, an estimated $143.
Barclays first reported a position in PetMed Express in Q2 2013 and held it in 43 quarters.
Barclays's PetMed Express position peaked at $2.82M in Q2 2020.
51 funds tracked by Wall St. Rank held PetMed Express as of Q4 2025.

Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.